CELL INTELLIGENCE · 肿瘤细胞治疗研究

烟酰胺单核苷酸增强靶向 MSLN 的 CAR-NK 细胞治疗在卵巢癌中的抗肿瘤疗效

Nicotinamide mononucleotide potentiates the anti-tumor efficacy of CAR-NK cell therapy targeting MSLN in ovarian cancer.

增强 PD-L1 靶向提升 FOLR1- CAR NK92 细胞对卵巢癌的杀伤活性

Enhanced PD-L1 targeting boosts the cytotoxic activity of FOLR1- CAR NK92 cells against ovarian cancer.

不同的免疫细胞经嵌合抗原受体修饰后正被应用于卵巢癌：哪一种最有效？

Different Immune Cells Modified With Chimeric Antigen Receptors Are Being Applied to Ovarian Cancer: Which Is the Most Effective?

卵巢癌中的 NK 细胞治疗：从临床前潜力到临床应用与联合策略

Natural Killer Cell Therapy in Ovarian Cancer: From Preclinical Potentials to Clinical Applications and Combination Strategies.

嵌合抗原受体 NK 细胞治疗卵巢癌的疗效：临床前研究的荟萃分析

Efficacy of chimeric antigen receptor natural killer cells in treatment of ovarian cancer. A meta-analysis of pre-clinical studies.

信号传导完整的膜结合 IL-15 赋予 CAR-NK 细胞强效抗肿瘤活性和安全性

Signaling intact membrane-bound IL-15 enables potent anti-tumor activity and safety of CAR-NK cells.

头对头比较研究显示，与 sIL-15 相比，信号完整的 mbIL-15 显著提高了 CAR-NK 细胞的疗效和安全性，为未来临床开发提供了临床前证据。

Neoleukin-2/15 装甲 CAR-NK 细胞通过 c-Myc/NRF1 激活在实体瘤中维持优越的治疗效果

Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc/NRF1 activation.

人胚胎干细胞来源的间皮素 CAR 工程化 NK 细胞抑制动物体内人卵巢癌进展

Mesothelin CAR-engineered NK cells derived from human embryonic stem cells suppress the progression of human ovarian cancer in animals.

用 CAR-NK 细胞靶向 ROBO1 以对抗卵巢癌原发肿瘤细胞和类器官的有前景方法

Promising approach for targeting ROBO1 with CAR NK cells to combat ovarian cancer primary tumor cells and organoids.

卵巢癌 CAR-T 治疗：最新进展与未来方向

CAR-T therapy for ovarian cancer: Recent advances and future directions.